Symmetry Therapeutics Overview
- Latest Deal Type
Out of Business
Symmetry Therapeutics General Information
Provider of a mitochondrial carrier drug platform intended to treat common and rare metabolic diseases. The company's platform target metabolite carrier proteins, enabling patients to get meaningful therapeutic options.
Want to dig into this profile?
We’ll help you find what you need
Symmetry Therapeutics Signals
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog »
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »